Search research articles
Contact Us
Filters
Showing results (281-290 of 387) with videos related to
Page
of 39
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
Andrew M Evens, Fangxin Hong, Thomas M Habermann, et al.
British Journal of Haematology
|
May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Narendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Blood
|
May 24, 2013
Outcomes of patients with POEMS syndrome treated initially with radiation
Michael S Humeniuk, Morie A Gertz, Martha Q Lacy, et al.
British Journal of Haematology
|
April 14, 2006
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia
Irene M Ghobrial, Rafael Fonseca, Morie A Gertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2006
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia
Tait D Shanafelt, Thomas E Witzig, Stephanie R Fink, et al.
Blood Cancer Journal
|
August 3, 2018
History of autoimmune conditions and lymphoma prognosis
Geffen Kleinstern, Matthew J Maurer, Mark Liebow, et al.
Mayo Clinic Proceedings
|
October 3, 2007
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma
Martha Q Lacy, Morie A Gertz, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2013
Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma
Prashant Kapoor, Shaji K Kumar, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study
Grzegorz S Nowakowski, Betsy LaPlant, William R Macon, et al.
British Journal of Haematology
|
March 10, 2026
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes
George A Cholack, Raphael Mwangi, Prokop Vodička, et al.
Page
of 39
Search research articles
Search
Showing results (281-290 of 387) with videos related to
Sort By:
Page
of 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2020
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
Andrew M Evens, Fangxin Hong, Thomas M Habermann, et al.
British Journal of Haematology
|
May 4, 2017
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma
Narendranath Epperla, Anthony Q Pham, Brian L Burnette, et al.
Blood
|
May 24, 2013
Outcomes of patients with POEMS syndrome treated initially with radiation
Michael S Humeniuk, Morie A Gertz, Martha Q Lacy, et al.
British Journal of Haematology
|
April 14, 2006
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia
Irene M Ghobrial, Rafael Fonseca, Morie A Gertz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2006
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia
Tait D Shanafelt, Thomas E Witzig, Stephanie R Fink, et al.
Blood Cancer Journal
|
August 3, 2018
History of autoimmune conditions and lymphoma prognosis
Geffen Kleinstern, Matthew J Maurer, Mark Liebow, et al.
Mayo Clinic Proceedings
|
October 3, 2007
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma
Martha Q Lacy, Morie A Gertz, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2013
Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma
Prashant Kapoor, Shaji K Kumar, Angela Dispenzieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2014
Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study
Grzegorz S Nowakowski, Betsy LaPlant, William R Macon, et al.
British Journal of Haematology
|
March 10, 2026
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes
George A Cholack, Raphael Mwangi, Prokop Vodička, et al.
Page
of 39